Izilendustat
Modify Date: 2025-08-21 17:36:13
Izilendustat structure
|
Common Name | Izilendustat | ||
|---|---|---|---|---|
| CAS Number | 1303512-02-8 | Molecular Weight | 433.93 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C22H28ClN3O4 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of IzilendustatIzilendustat is a potent inhibitor of prolyl hydroxylase which can stabilize hypoxia inducible factor- 1 alpha (HIF- lα) and hypoxia inducible factor-2 (HIF-2). Izilendustat has the potential for researching diseases that relate to the body’s inmmune response like colitis and other inflammatory bowel diseases (extracted from patent WO2011057115A1 and WO2011057121A1)[1][1]. |
| Name | tert-Butyl 4-((1-(4-chlorobenzyl)-3-hydroxy-2-oxo-1,2-dihydropyridin-4-yl)methyl)piperazine-1-carboxylate |
|---|
| Description | Izilendustat is a potent inhibitor of prolyl hydroxylase which can stabilize hypoxia inducible factor- 1 alpha (HIF- lα) and hypoxia inducible factor-2 (HIF-2). Izilendustat has the potential for researching diseases that relate to the body’s inmmune response like colitis and other inflammatory bowel diseases (extracted from patent WO2011057115A1 and WO2011057121A1)[1][1]. |
|---|---|
| Related Catalog | |
| References |
[1]. Joseph H, et al. Prolyl hydroxylase inhibitors. Patent WO2011057115A1. [2]. Joseph H, et al. Compositions and methods for treating colitis. Patent WO2011057121A1. |
| Molecular Formula | C22H28ClN3O4 |
|---|---|
| Molecular Weight | 433.93 |
| Storage condition | 2-8°C |